Mesenchymal stem cells (MSCs) are multipotent, meaning they can differentiate into various types of specialised cells. They primarily form connective tissues within the musculoskeletal system, including cartilage (chondrocytes), bone (osteocytes), muscle (myocytes) and fat (adipocytes).

Cryogenic sample storage technology has evolved significantly to meet the growing demands of customers, especially in industries like biopharma, where stringent regulatory compliance and operational efficiency are paramount. The transition from small aluminium vessels to large stainless-steel ones reflects the increasing need for high-capacity, efficient vapour-phase storage that can safeguard valuable biological materials.

Further to our previous article where we looked at the challenges faced by ultra-low temperature and cryogenic storage environments, and the best ways to address them to create stable, auditable samples, here are some best practices and tools for optimising sample tracking in cryogenic storage environments:

Under the new partnership agreement, Biopharma Group assumes exclusive responsibility as technical service provider across the UK & Ireland, supporting IC Biomedical's full range of cryogenic storage solutions. This is in addition to the existing agreement covering the sales of the TW (IC Biomedical) range of cryogenic stainless steel storage vessels.

Under the new partnership agreement, Biopharma Group assumes exclusive responsibility as technical service provider across the UK & Ireland, supporting IC Biomedical's full range of cryogenic storage solutions. This is in addition to the existing agreement covering the sales of the TW (IC Biomedical) range of cryogenic stainless steel storage vessels.

In our latest video, we look at the pressing challenges faced by embryologists and fertility clinics, especially in the realm of sample storage. With nearly 100,000 embryos frozen annually in the UK, storage has become a critical issue

In the evolving landscape of Biobanking and cell banking, the integration of automation can be a transformative force, revolutionising the way laboratories store, manage and make use of cryogenically preserved cells and tissues. As the demand for precision, efficiency and scalability continues to rise, automation stands at the forefront, offering many benefits to modern biobanking laboratories.

Cell and gene therapies are innovative approaches to treating diseases by harnessing the power of a patient's own cells or by introducing genetic material to correct or modify cellular functions. These therapies have the potential to revolutionise the field of medicine and provide new treatment options for a wide range of diseases, including genetic disorders, cancer, cardiovascular diseases, neurodegenerative disorders and autoimmune diseases.

Samples are at the heart of every lab. They are often valuable, precious and contain information that could answer novel research questions. This could lead to new drug discoveries, provide people with life-saving treatments, or, in the case of infertility clinics, helping to create lives. Therefore, in fertility clinics, academia, biobanks, research and pharmaceutical laboratories, safe handling and storage of biological samples is paramount to achieve successful results.